证券代码：600128 证券简称：苏豪弘业 公告编号：临 2025-056 苏豪弘业股份有限公司 关于 2025 年限制性股票激励计划内幕信息知情人 买卖公司股票情况的自查报告 本董事会及董事会全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 苏豪弘业股份有限公司（以下简称"公司"）根据《上市公司信息披露管理 办法》《上市公司监管指引第 5 号——上市公司内幕信息知情人登记管理制度》 （以下简称"《内幕信息知情人登记管理制度》"）《上市公司股权激励管理办 法》（以下简称"《管理办法》"）等规范性文件的要求，针对公司 2025 年限 制性股票激励计划（以下简称"激励计划"或"本次激励计划"）采取了充分必 要的保密措施，同时对激励计划的内幕信息知情人做了登记。 2、激励计划的内幕信息知情人均填报了《内幕信息知情人登记表》。 3、公司向中国证券登记结算有限责任公司上海分公司（以下简称"中国结 算公司"）就核查对象在自查期间买卖公司股票情况进行了查询确认，并由中国 结算公司出具了查询证明。 二、核查对象买卖公司股票的情况说明 根据中国结算公司出具的《 ...

证券代码：600128 证券简称：苏豪弘业 公告编号：临 2025-055 苏豪弘业股份有限公司 2025年第二次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 10 月 9 日 (二)股东会召开的地点：南京市中华路 50 号弘业大厦 12 楼会议室 (三)出席会议的普通股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 350 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 80,615,419 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 32.6685 | 1、 议案名称：关于《公司 2025 年限制性股票激励计划（草案）》及其摘要的议 案 审议结果：通过 表决情况： | 股东类型 | 同意 | | 反对 | | 弃权 | | | --- | --- | --- | --- | --- | ...

www.grandall.com.cn 中国江苏省南京市汉中门大街 309 号 B 座 5 层、7-8 层（210036） 5F, 7-8/F, Block B, 309 Hanzhongmen Dajie, Nanjing, China, 210036 Tel: 86-25-89660900 Fax: 86-25-89660966 苏豪弘业股份有限公司 国浩律师（南京）事务所 关于 2025 年第二次临时股东会的法律意见书 致：苏豪弘业股份有限公司 根据《中华人民共和国公司法》(下称"《公司法》")、《中华人民共和国 证券法》(下称"《证券法》")、《上市公司股东会规则》（下称"《股东会规 则》"）、《上海证券交易所上市公司自律监管指引第1号——规范运作》(下称 "《监管指引第1号》")及《苏豪弘业股份有限公司章程》(下称"《公司章程》") 的规定，国浩律师（南京）事务所（下称"本所"）接受苏豪弘业股份有限公司 （下称"公司"）的委托，指派本所律师出席公司2025年第二次临时股东会（下 称"本次股东会"或"本次会议"），对本次股东会的召集和召开程序、出席会 议人员的资格、召集人资格以及会议表决程序和表决结果 ...

Core Viewpoint - Suhao Hongye Co., Ltd. is engaged in trade, culture, and investment, with a focus on export and import businesses, particularly in toys, pet products, medical devices, and fertilizers [2][7]. Company Overview - Suhao Hongye Co., Ltd. was established on June 30, 1994, and listed on September 1, 1997. The company is located in Nanjing, Jiangsu Province [7]. - The main business revenue composition includes 98.45% from product sales, 1.05% from engineering projects and consulting services, and 0.51% from other sources [7]. - As of June 30, the number of shareholders is 27,700, a decrease of 39.99% from the previous period, while the average circulating shares per person increased by 66.64% [7]. Financial Performance - For the first half of 2025, the company achieved a revenue of 3.919 billion yuan, representing a year-on-year growth of 10.73%. The net profit attributable to the parent company was 26.296 million yuan, up 34.72% year-on-year [7]. - The company has distributed a total of 503 million yuan in dividends since its A-share listing, with 74.03 million yuan distributed in the last three years [8]. Investment and Subsidiaries - The company holds a 16.31% stake in Hongye Futures, which is listed on the Hong Kong Stock Exchange [3]. - Suhao Hongye invested 12 million yuan for a 24% stake in Jiangsu Hongrui Technology Investment Company, the first venture capital firm in Jiangsu Province focused on the biomedical field [3]. Market Activity - On October 9, the stock price of Suhao Hongye remained unchanged at 0.00%, with a trading volume of 48.76 million yuan and a turnover rate of 1.89%. The total market capitalization is 2.579 billion yuan [1]. - The stock has seen a net outflow of 2.4458 million yuan from major funds today, with a total net outflow of 85.3665 million yuan over the past 20 days [5].

Core Viewpoint - Suhao Hongye has successfully received full repayment of a trust product, positively impacting its financial performance and expected profit [1][2]. Group 1: Trust Product Repayment - The company announced the full repayment of the Zhongrong-Zhuoli No. 122 collective fund trust plan, totaling 15,257,424.66 yuan [1]. - The repayment includes both the principal and the most recent earnings from the trust product [1]. - This repayment is expected to increase the company's total profit by approximately 4.5 million yuan [1]. Group 2: Financial Impact - The company will process the financial impact according to enterprise accounting standards, with the final effect to be confirmed in the audited periodic report [2].

Core Viewpoint - Suhao Hongye (600128.SH) has received full principal and recent earnings from the Zhongrong-Zhuoli No. 122 Collective Fund Trust Plan, totaling 15,257,424.66 yuan, which positively impacts the company's profit [1] Group 1 - The company confirmed a fair value change loss during the trust product's duration based on its fair value situation [1] - The full recovery of the principal and earnings from the trust product is expected to increase the company's total profit by approximately 4.5 million yuan [1]

Core Viewpoint - Suhao Hongye (600128.SH) has received the full principal and recent earnings from the Zhongrong-Zhuoli No. 122 Collective Fund Trust Plan, totaling 15,257,424.66 yuan, which positively impacts the company's profit [1] Financial Impact - The company confirmed a portion of fair value change losses during the trust product's duration based on its fair value situation [1] - The full recovery of the principal and earnings from the trust product is expected to increase the company's total profit by approximately 4.5 million yuan [1]

苏豪弘业股份有限公司 董事会 苏豪弘业股份有限公司 关于相关信托产品已兑付的公告 本公司董事会及董事会全体董事保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 公司将根据企业会计准则的规定进行相关会计处理，最终财务影响以经审计 的定期报告为准。 证券代码：600128 证券简称：苏豪弘业 公告编号：临 2025-054 特此公告。 苏豪弘业股份有限公司（以下简称"苏豪弘业"或"公司"）前期披露了《苏 豪弘业关于部分信托产品延期兑付的提示性公告》，详情参见公司于2023年12月5 日在《上海证券报》《中国证券报》及上海证券交易所网站（http://www.sse.com.cn） 披露的"《苏豪弘业关于部分信托产品延期兑付的提示性公告》（临2023-077）"。 近日，公司收到中融-卓利122号集合资金信托计划（以下简称"卓利122号"） 兑付的全额本金及最近一期收益，共计15,257,424.66元。 在该信托产品存续期间，公司基于其公允价值情况，确认了部分公允价值变 动损失。目前该信托产品本金及收益已全额收回，对公司公允价值变动损益产生 正向影响，预 ...

Group 1 - The company held its fifth board meeting on September 29, 2025, where several important resolutions were passed [1] - Amendments to the company's articles of association were approved, including renaming "shareholders' meeting" to "shareholders' assembly" and "audit committee" to "audit committee" [1] - The board size was adjusted from 7 to 8 members, maintaining 3 independent directors and increasing non-independent directors from 4 to 5, including 1 employee representative director [1] Group 2 - To reduce costs and improve efficiency, the company plans to close its Hefei branch, with related operations being merged into the Wuhu branch or adjusted based on personnel [1] - The company will revise several governance systems, including the "Related Party Transaction Management System" and the "Fundraising Management System," to comply with the latest legal requirements [1] - A proposal was made to hold the second extraordinary shareholders' meeting of 2025 at a later date, with announcements and notifications to follow [1]

Core Viewpoint - The announcement details the public disclosure and verification of the list of incentive recipients for the 2025 Restricted Stock Incentive Plan of Suhao Hongye Co., Ltd, confirming compliance with relevant laws and regulations [1][3][4]. Disclosure and Verification Process - The company disclosed the draft of the 2025 Restricted Stock Incentive Plan and the list of incentive recipients on the Shanghai Stock Exchange website on July 17, 2025, with a public notice period from August 18 to August 27, 2025 [1][2]. - No objections were received from individuals or organizations regarding the proposed incentive recipients during the public notice period [2]. Committee Verification Opinions - The remuneration and assessment committee confirmed that the proposed incentive recipients meet the qualifications set forth in the Company Law, Securities Law, and other relevant regulations, with no disqualifying conditions present [3][4]. - The recipients include company directors, senior management, and key personnel, all of whom are employed by the company or its subsidiaries [3][4]. - The list excludes external directors, independent directors, and shareholders or actual controllers holding more than 5% of the company's shares [3][4].